NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/04/2026
Back to search
Official data from USPTO
RDT RARE DISEASE THERAPEUTICS, INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
03/24/2026
Trademark type
Combined
Nice classes
5
Filing date
05/06/2003
Registration date
02/21/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/04/2026
Last transaction
03/24/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2003-01-00
First use in commerce
2003-01-00
Drawing code
3
Owner type
03
Owner location
Franklin, TN, US
Examiner
CARLYLE, SHAUNIA P
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Rare Disease Therapeutics, Inc.
Rare Disease Therapeutics, Inc.
Representatives
Stephanie SCRUGGS BRADLEY ARANT BOULT CUMMINGS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for use in the treatment of orphan diseases and disorders
Publications
History of USPTO decisions and trademark events.
41 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/04/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/04/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/04/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
12/09/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/21/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/31/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/05/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/05/2018
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/05/2016
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/05/2016
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/05/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/04/2016
E89R
TEAS SECTION 8 & 9 RECEIVED
01/27/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/12/2015
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/21/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/26/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/26/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/25/2011
E815
TEAS SECTION 8 & 15 RECEIVED
06/13/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
02/21/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/12/2005
ALIE
ASSIGNED TO LIE
12/09/2005
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/08/2005
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/21/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2005
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2005
GNRT
NON-FINAL ACTION E-MAILED
06/08/2005
CNRT
SU - NON-FINAL ACTION - WRITTEN
06/08/2005
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/26/2005
IUAF
USE AMENDMENT FILED
05/16/2005
EISU
TEAS STATEMENT OF USE RECEIVED
05/16/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/16/2004
PUBO
PUBLISHED FOR OPPOSITION
08/24/2004
NPUB
NOTICE OF PUBLICATION
08/04/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/08/2004
EMRV
EMAIL RECEIVED
05/14/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2004
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/04/2004
GNRT
NON-FINAL ACTION E-MAILED
11/05/2003
DOCK
ASSIGNED TO EXAMINER
11/05/2003
Continuous trademark protection
Get notified about every new filing that threatens RDT RARE DISEASE THERAPEUTICS, INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.